Novel Antimicrobials and AMR Diagnostics 2019

About

For more than 30 years, Berlin-based BIOCOM AG is a life science focused information provider, offering communication services, organizing events and publishing European media in the fields of pharma, biotech and bioeconomy. The European Biotechnology Magazine with its website european-biotechnology.com is the major media partner of the Berlin Conference. It is a quarterly publication with a distribution of 10,000 copies across Europe which is supported by many national biotech associations.

The “Berlin Conference on Life Sciences” was established by BIOCOM AG eleven years ago as an event format to discuss the challenges of SME-driven innovation for the health market and to offer a platform for meeting experts from business, science, finance, regulatory affairs and intellectual property (see History).

Other international events organized by BIOCOM AG include: 


Since 2017, the “Berlin Conference on Life Sciences” focuses on novel antimicrobials, with the BEAM Alliance stepping in as one of its major supporting partners. Launched in June 2015, the BEAM (Biotech companies in Europe combating AntiMicrobial Resistance) Alliance is a strong network of approx. 50 small and medium-sized European biopharmaceutical companies committed to developing innovative products for fending off antibiotic-resistant pathogens. The aim is to establish the Berlin Conference as the one-stop-shop in Europe to meet all AMR relevant stakeholders in industry, finance, policy and application-oriented science.